New Ru(II)-caged abiraterone complexes were synthesized that exhibit strong absorption in the visible region and release the steroidal CYP17A1 inhibitor abiraterone upon exposure to low energy visible light in buffer and prostate cancer cells. Photoinduced release results in abiraterone binding to its CYP17A
I'm not a big fan of studies. I realize they are generally good things. I mean, we should study things to better understand them. But these days they're almost as ubiquitous as the variables that sway their conclusions.